Filing Details

Accession Number:
0001237899-18-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-14 16:49:14
Reporting Period:
2018-12-12
Accepted Time:
2018-12-14 16:49:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013064 Roy P Vagelos 777 Old Saw Mill River Road
Tarrytown NY 10591
Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-29 12,500 $0.00 387,449 No 5 G Direct
Common Stock Disposition 2018-11-13 37,209 $0.00 350,240 No 5 G Direct
Common Stock Disposition 2018-11-15 19,202 $0.00 331,038 No 5 G Direct
Common Stock Disposition 2018-11-16 16,161 $0.00 314,877 No 5 G Direct
Common Stock Disposition 2018-12-12 6 $382.32 2,304 No 4 S Indirect By 401(k) Plan
Common Stock Disposition 2018-10-04 521 $0.00 147,413 No 5 G Indirect by CLAT
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 5 G Direct
No 4 S Indirect By 401(k) Plan
No 5 G Indirect by CLAT
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2018-12-12 36,273 $0.00 36,273 $381.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,273 2028-12-12 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 83,652 Indirect by Spouse as Trustee
Common Stock 1,203 Indirect by trust for grandch
Footnotes
  1. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
  2. The stock option award vests in four equal annual installments, commencing one year after the date of grant.